Cellular Dynamics Pulls In $40 Million
This article was originally published in Start Up
Executive Summary
Cellular Dynamics International, which manufactures human cells for drug assays,has tapped a closely connected syndicate of investors for nearly $41 million in Series B funding, bringing total investment in the firm to $70 million. The fundraising total is impressive for a start-up in a highly speculative area of biotech where VCs have been cautious about committing capital.